• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pathogens . SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia

tetano

Editor, Senior Moderator
Pathogens


. 2021 Jun 20;10(6):774.
doi: 10.3390/pathogens10060774.
SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia


Tatjana Vilibic-Cavlek[SUP] 1 2 [/SUP], Vladimir Stevanovic[SUP] 3 [/SUP], Maja Ilic[SUP] 4 [/SUP], Ljubo Barbic[SUP] 3 [/SUP], Krunoslav Capak[SUP] 5 [/SUP], Irena Tabain[SUP] 1 [/SUP], Jasna Lenicek Krleza[SUP] 6 [/SUP], Thomas Ferenc[SUP] 7 [/SUP], Zeljka Hruskar[SUP] 1 [/SUP], Renata Zrinski Topic[SUP] 6 [/SUP], Vanja Kaliterna[SUP] 8 [/SUP], Arlen Antolovic-Pozgain[SUP] 9 [/SUP], Jasmina Kucinar[SUP] 10 [/SUP], Iva Koscak[SUP] 11 [/SUP], Dijana Mayer[SUP] 12 [/SUP], Mario Sviben[SUP] 2 13 [/SUP], Ljiljana Antolasic[SUP] 1 [/SUP], Ljiljana Milasincic[SUP] 1 [/SUP], Lovro Bucic[SUP] 4 [/SUP], Ivana Ferencak[SUP] 1 [/SUP], Bernard Kaic[SUP] 4 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus with a pandemic spread. So far, a total of 349,910 SARS-CoV-2 cases and 7687 deaths were reported in Croatia. We analyzed the seroprevalence and neutralizing (NT) antibody response in the Croatian general population after the first (May-July 2020) and second (December 2020-February 2021) pandemic wave. Initial serological testing was performed using a commercial ELISA, with confirmation of reactive samples by a virus neutralization test (VNT). A significant difference in the overall seroprevalence rate was found after the first (ELISA 2.2%, VNT 0.2%) and second waves (ELISA 25.1%, VNT 18.7%). Seropositive individuals were detected in all age groups, with significant differences according to age. The lowest prevalence of NT antibodies was documented in the youngest (<10 years; 16.1%) and the oldest (60-69/70+ years; 16.0% and 12.8%, respectively) age groups. However, these age groups showed the highest median NT titers (32-64). In other groups, seropositivity varied from 19.3% to 21.5%. A significant weak positive correlation between binding antibody level as detected by ELISA and VNT titer (rho = 0.439, p < 0.001) was observed. SARS-CoV-2 NT antibody titers seem to be age-related, with the highest NT activity in children under 10 years and individuals above 50 years.

Keywords: COVID-19; Croatia; ELISA; SARS-CoV-2; VNT; seroprevalence.
 
Back
Top Bottom